The programme is designed to help over 100,000 female entrepreneurs globally to safeguard their business from Covid-19. Many women are struggling to keep their businesses afloat in these difficult times, and lack the support they need to adapt and sustain their businesses.
Latest from the network
Looking for something specific?
The programme is designed to help over 100,000 female entrepreneurs globally to safeguard their business from Covid-19. Many women are struggling to keep their businesses afloat in these difficult times, and lack the support they need to adapt and sustain their businesses.
The HR Dept writes:
The relaxation of lockdown restrictions is goods news for many businesses; even the hard-pressed leisure and hospitality sectors have cause for cautious optimism as they make tentative plans to start trading again.
Faced with the biggest global crisis in decades, many women entrepreneurs within low and middle income countries are experiencing severe impacts on their businesses, with the risk that this will lead to significant negative effects on their families and their economies.
Professor Reik is an internationally renowned expert in the field of epigenetics and has led the Institute’s Epigenetics research programme since 2008.
SAFIRA™ (SAFer Injection for Regional Anesthesia) is an FDA approved revolutionary new technology that transforms regional anesthesia into a one person procedure, putting control in the hands of the anesthesiologist. A unique safety solution monitors and limits injection pressure.